Cardiovascular Diabetology

1. Cardiovasc Diabetol29 Jun 2023

   Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism?

   Cross-sectional studyComplications

2. Cardiovasc Diabetol29 Jun 2023

   The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study

   Cohort studyComplications

3. Cardiovasc Diabetol29 Jun 2023

   Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study

   Cross-sectional studyT2D & other

4. Cardiovasc Diabetol29 Jun 2023

   Triglyceride glucose index is a significant predictor of severe disturbance of consciousness and all-cause mortality in critical cerebrovascular disease patients

   Cohort study

5. Cardiovasc Diabetol28 Jun 2023

   Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study

   Meta-analysisT2D & other

6. Cardiovasc Diabetol28 Jun 2023

   Incremental effect of coronary obstruction on myocardial microvascular dysfunction in type 2 diabetes mellitus patients evaluated by first-pass perfusion CMR study

   Cross-sectional studyT2D & other

7. Cardiovasc Diabetol28 Jun 2023

   Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

   Secondary analysisT2D & other

8. Cardiovasc Diabetol26 Jun 2023

   Independent and joint associations between the triglyceride-glucose index and NT-proBNP with the risk of adverse cardiovascular events in patients with diabetes and acute coronary syndrome: a prospective cohort study

   Cohort studyT2D & other

9. Cardiovasc Diabetol26 Jun 2023

   Prognostic impacts of diabetes status and lipoprotein(a) levels in patients with ST-segment elevation myocardial infarction: a prospective cohort study

   Cohort studyT2D & other

10. Cardiovasc Diabetol26 Jun 2023

    The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol/L

    Cohort studyLipids & liver

11. Cardiovasc Diabetol26 Jun 2023

    Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction

    Cross-sectional studyComplications

12. Cardiovasc Diabetol26 Jun 2023

    Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort : Rapid kidney function decline and heart failure in T2D

    Secondary analysisT2D & other

13. Cardiovasc Diabetol23 Jun 2023

    Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes

    Cohort studyT2D & other

14. Cardiovasc Diabetol22 Jun 2023

    Differential expression of coagulation pathway-related proteins in diabetic urine exosomes

    Mechanistic studyT2D & other

15. Cardiovasc Diabetol22 Jun 2023

    Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

    Randomized controlled trialT2D & other

16. Cardiovasc Diabetol17 Jun 2023

    Association of dynamic change of triglyceride-glucose index during hospital stay with all-cause mortality in critically ill patients: a retrospective cohort study from MIMIC IV2.0

    Cohort studyLipids & liver

17. Cardiovasc Diabetol16 Jun 2023

    Identification of candidate metabolite biomarkers for metabolic syndrome and its five components in population-based human cohorts

    Cohort studyT2D & other

18. Cardiovasc Diabetol16 Jun 2023

    Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study

    Cohort studyT2D & other

19. Cardiovasc Diabetol14 Jun 2023

    Machine learning-based models to predict one-year mortality among Chinese older patients with coronary artery disease combined with impaired glucose tolerance or diabetes mellitus

    Diagnostic or prognostic studyT2D & other

20. Cardiovasc Diabetol13 Jun 2023

    Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database

    Cohort studyLipids & liver

21. Cardiovasc Diabetol12 Jun 2023

    Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus–a multicenter study in China

    Cross-sectional studyT2D & other

22. Cardiovasc Diabetol12 Jun 2023

    Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study

    Cohort studyT2D & other

23. Cardiovasc Diabetol12 Jun 2023

    Duration-dependent impact of cardiometabolic diseases and multimorbidity on all-cause and cause-specific mortality: a prospective cohort study of 0.5 million participants

    Cohort study

24. Cardiovasc Diabetol12 Jun 2023

    Glycemic variability and in-hospital death of critically ill patients and the role of ventricular arrhythmias

    Cohort study

25. Cardiovasc Diabetol9 Jun 2023

    Triglyceride–glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension

    Cohort study

26. Cardiovasc Diabetol9 Jun 2023

    The change of triglyceride-glucose index may predict incidence of stroke in the general population over 45 years old

    Cohort studyT2D & other

27. Cardiovasc Diabetol31 May 2023

    The impact of diabetes on the relationship of coronary artery disease and outcome: a study using multimodality imaging

    Cohort studyT2D & other

28. Cardiovasc Diabetol31 May 2023

    Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression

    Cohort studyLipids & liver

29. Cardiovasc Diabetol27 May 2023

    Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence

    Cohort studyT2D & other

30. Cardiovasc Diabetol27 May 2023

    The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China

    Cohort studyLipids & liver

31. Cardiovasc Diabetol24 May 2023

    Sodium-glucose cotransporter 2 inhibitor may not prevent atrial fibrillation in patients with heart failure: a systematic review

    Meta-analysisT2D & other

32. Cardiovasc Diabetol22 May 2023

    Evolocumab attenuate pericoronary adipose tissue density via reduction of lipoprotein(a) in type 2 diabetes mellitus: a serial follow-up CCTA study

    Cohort studyT2D & other

33. Cardiovasc Diabetol20 May 2023

    Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease

    Cohort studyT2D & other

34. Cardiovasc Diabetol20 May 2023

    Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study

    Secondary analysisT2D & other

35. Cardiovasc Diabetol18 May 2023

    Impact of mental disorders on the risk of heart failure among Korean patients with diabetes: a cohort study

    Cohort studyT2D & other

36. Cardiovasc Diabetol18 May 2023

    U-shaped association between the triglyceride–glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease

    Cohort studyLipids & liver

37. Cardiovasc Diabetol15 May 2023

    Effects of metabolic parameters’ variability on cardiovascular outcomes in diabetic patients

    Cohort studyT2D & other

38. Cardiovasc Diabetol13 May 2023

    Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: a systematic review and exposure-effect meta-analysis

    Meta-analysisLipids & liver

39. Cardiovasc Diabetol13 May 2023

    Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit

    Cohort studyLipids & liver

40. Cardiovasc Diabetol13 May 2023

    Association between the triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome

    Cohort studyLipids & liver

All 1,291 Briefs in ExploreShowing Briefs 1,161–1,200 of 1,291, newest first